Clozapine-carboxylic Acid Plasticized Co-amorphous Dispersions: Preparation, Characterization and Solution Stability Evaluation
Overview
Affiliations
This study addressed the possibility of forming of co-amorphous systems between clozapine (CZ) and various carboxylic acid plasticizers (CAPs). The aim was to improve the solubility and oral bioavailability of clozapine. Co-amorphous dispersions were prepared using modified solvent evaporation methodology at drug/plasticizer stoichiometric ratios of 1:1, 1:1.5 and 1:2. Solid state characterization was performed using differential scanning calorimetry, X-ray diffraction and infra red spectroscopy. Highly soluble homogeneous co-amorphous dispersions were formed between clozapine and CAPs via hydrogen bonding. The co-amorphous dispersions formed with tartaric acid (1:2) showed the highest dissolution percentage (>95% in 20 minutes) compared to pure crystalline CZ (56%). Highly stable solutions were obtained from co-amorphous CZ-citric and CZ-tartaric acid at 1:1.5 molar ratio. The prepared dispersions suggest the possibility of peroral or sublingual administration of highly soluble clozapine at a reduced dose with the great chance to bypass the first pass metabolism.
Qadir A, Jan S, Shoaib M, Sikandar M, Yousuf R, Ali F Sci Rep. 2025; 15(1):1204.
PMID: 39774012 PMC: 11707343. DOI: 10.1038/s41598-024-81918-6.
Lombardo R, Ruponen M, Rautio J, Ghelardini C, Di Cesare Mannelli L, Calosi L Pharmaceutics. 2023; 15(5).
PMID: 37242796 PMC: 10224374. DOI: 10.3390/pharmaceutics15051554.
Islam N, Naveed Umar M, Khan E, Al-Joufi F, Abed S, Said M Antibiotics (Basel). 2022; 11(6).
PMID: 35740203 PMC: 9220774. DOI: 10.3390/antibiotics11060797.
Hu D, Chen X, Li D, Zhang H, Duan Y, Huang Y Pharmaceutics. 2022; 14(3).
PMID: 35335977 PMC: 8949968. DOI: 10.3390/pharmaceutics14030603.
Wiergowska G, Ludowicz D, Wdowiak K, Miklaszewski A, Lewandowska K, Cielecka-Piontek J Pharmaceuticals (Basel). 2021; 14(5).
PMID: 34064796 PMC: 8151567. DOI: 10.3390/ph14050453.